Leukemoid Reaction: Types, Symptoms, Causes, Diagnosis, and Treatment
A comprehensive overview of leukemoid reactions, explaining causes, symptoms, diagnosis, and how they differ from leukemia.

A leukemoid reaction is a dramatic, short-term increase in your white blood cell (WBC) count, sometimes easily mistaken for leukemia. While this condition is not a cancer in itself, it signals a need for further investigation to find and manage any underlying medical issues. This article delivers a detailed, up-to-date exploration of leukemoid reactions—including definitions, types, symptoms, causes, risk factors, diagnosis, treatments, prognosis, and frequently asked questions.
What Is a Leukemoid Reaction?
A leukemoid reaction is defined as a white blood cell count that exceeds 50,000 cells per microliter (µL) of blood. For perspective, normal WBC counts are typically in the range of:
Demographic | White Blood Cells per µL |
---|---|
Men | 5,000–10,000 |
Women (nonpregnant) | 4,500–11,000 |
Children | 5,000–10,000 |
In a leukemoid reaction, bloodwork tends to show:
- Significant elevation in mature neutrophils
- Presence of immature granulocytes
These cell types play vital roles in your immune defense, especially in responding quickly to infections and inflammation. While leukemoid reaction may resemble leukemia in lab results, it is notable for being a reactive process—a sign of the body dealing with another underlying health issue—rather than a primary blood cancer.
Types of Leukemoid Reaction
The classification of a leukemoid reaction is based on which subgroup of white blood cell is predominantly elevated. The main types include:
- Granulocytic reaction: The most common type, characterized by a marked increase in neutrophils. This often signals infection, certain cancers, or inflammatory conditions.
- Lymphocytic reaction: Defined by a rise in lymphocytes, which is often associated with immune responses, sometimes seen during viral infections or when the body mounts a response against cancer cells.
- Monocytic reaction: Marked by an increase in monocytes, these arise in the context of infection or tissue injury.
Granulocytic Leukemoid Reaction
Primarily seen in bacterial infections, severe stress, inflammation, or some cancer types.
Lymphocytic Leukemoid Reaction
May occur due to disease processes that involve significant immune activity including certain viral infections and immunological responses.
Monocytic Leukemoid Reaction
Sometimes observed in severe infections or recovery stages from chemotherapy or bone marrow suppression events.
Symptoms of Leukemoid Reaction
The symptoms of a leukemoid reaction generally mirror the symptoms of its underlying cause. Because this condition is a response rather than an illness of its own, presentations are highly variable. Common symptom categories include:
- Fever or chills
- Fatigue and weakness
- Frequent infections (reflective of underlying immune challenge or disease)
- Easy bleeding or bruising (less common, but possible if bone marrow is involved)
- Unintentional weight loss
Symptoms by likely underlying cause compared to leukemia:
Leukemia | Infection | Solid Cancer | Alcohol Hepatitis |
---|---|---|---|
Fever or chills | Fever or chills | Symptoms of affected organ | Fever |
Fatigue | Fatigue | Fatigue | Nausea or vomiting |
Weakness | Cough | Skin changes | Dry mouth |
Frequent infections | Sore throat | Change in bowel habits | Abdominal pain |
Unintentional weight loss | Diarrhea or vomiting | Unintentional weight loss | Unintentional weight loss |
Easy bruising or bleeding | Abdominal pain | Poor wound healing | Easy bleeding or bruising |
Swollen lymph nodes | Shortness of breath | Lump under the skin | Jaundice |
It’s important to note: Having a leukemoid reaction does not mean you have cancer. But it is a signal that your body is reacting to a potentially important health issue that needs diagnosis and possible treatment.
Causes and Risk Factors of Leukemoid Reaction
Leukemoid reactions can be triggered by a wide spectrum of conditions. The most common causes include:
- Infections: Such as bacterial infections (pneumonia, sepsis), viral illnesses, parasitic infections, and others.
- Solid tumors (cancers): Certain cancers, particularly those affecting organs like lungs or gastrointestinal tract, may provoke a strong white blood cell response.
- Drugs: Some medications (corticosteroids, growth factors like G-CSF, sulfa drugs, dapsone, ATRA) stimulate bone marrow activity leading to increased WBC production.
- Severe physical stressors and inflammation: Burns, trauma, major surgery, diabetic ketoacidosis.
- Organ necrosis: Tissue breakdown such as in hepatic necrosis or ischemic colitis.
- Alcoholic hepatitis: Significant liver inflammation related to alcohol use.
- Asplenia: The absence of a spleen increases susceptibility to infections and immune reactions.
- Paraneoplastic phenomena: Rarely, as a result of immune effects produced by cancers elsewhere in the body.
Certain rare, inherited, or metabolic conditions can also prompt leukemoid responses, especially in children with trisomy 21 (Down syndrome), where a higher incidence of leukemoid reactions is observed in infancy.
Diagnosis of Leukemoid Reaction
Diagnosing a leukemoid reaction requires careful exclusion of blood cancers, such as leukemia, particularly chronic myeloid leukemia (CML). The diagnostic process often includes:
- Detailed medical history and physical examination to identify infections, recent trauma, medications, or other risk factors
- Complete blood count (CBC) with differential to quantify and differentiate the types of white blood cells present
- Peripheral blood smear to look for the presence and maturity of WBCs
- Leukocyte alkaline phosphatase (LAP) score, which is typically high in leukemoid reaction but low in CML
- Advanced molecular testing for the Philadelphia chromosome or BCR/ABL fusion gene (seen in CML, not in reactive conditions)
- Other tests as indicated to identify underlying infections, inflammation, malignancy, or metabolic disturbance
Differences Between Leukemoid Reaction and Chronic Myeloid Leukemia (CML)
Feature | Leukemoid Reaction | Chronic Myeloid Leukemia (CML) |
---|---|---|
Origin | Reactive (secondary to illness/injury) | Malignant (primary blood cancer) |
WBC Types Elevated | Mature neutrophils, some immature granulocytes | Immature granulocytes, myeloblasts |
Leukocyte Alkaline Phosphatase Score | Normal or elevated | Typically low |
Philadelphia Chromosome | Absent | Present |
Resolution | Resolves with treatment of underlying cause | Requires targeted therapy |
Treatment for Leukemoid Reaction
There is no specific therapy for the leukemoid reaction itself; treatment is targeted at the underlying cause. The general treatment strategy involves:
- Managing the primary illness: Antibiotics for infections, anti-inflammatory drugs for inflammatory disorders, therapy for cancer if present, etc.
- Supportive care: May include fluids, nutrition, and symptomatic management during recovery from severe illness or trauma.
- Stopping causative medications: Discontinuation or adjustment of any medication suspected of causing the reaction.
Prompt identification and control of the underlying trigger are keys to resolution. As the acute condition improves, white blood cell counts usually return to normal ranges. Persistent or unexplained leukemoid reactions may necessitate a hematologist or oncologist consultation to exclude hidden malignancy or rare causes.
Outlook and Prognosis
The prognosis for a leukemoid reaction is closely tied to the underlying cause. Most leukemoid reactions are benign in themselves and resolve quickly once the precipitating factor is controlled or eliminated. However, because they often occur in response to serious illnesses such as sepsis or cancer, the overall health outcome depends significantly on the treatment and resolution of that main condition.
- Leukemoid reactions due to infections or medications typically resolve with appropriate management.
- If related to malignancy or severe organ damage, prognosis depends on the ability to successfully treat those core diseases.
- Complications are rare from the leukemoid reaction directly, but underlying conditions may lead to serious complications if not addressed promptly.
Frequently Asked Questions (FAQs)
What is the difference between a leukemoid reaction and leukemia?
A leukemoid reaction is a benign, reactive increase in white blood cells due to infection, inflammation, or stress, and resolves when the cause is managed. Leukemia is a malignant cancer of blood-forming cells in the bone marrow, requiring specific treatment and does not resolve without intervention.
How is leukemoid reaction diagnosed?
Diagnosis combines blood tests (CBC, white cell differential), blood smears, assessment of leukocyte alkaline phosphatase levels, exclusion of leukemia (especially via BCR/ABL genetic testing), and the search for a trigger such as infection or malignancy.
Can leukemoid reactions be prevented?
Because they are responses to other conditions, prevention focuses on avoiding or controlling underlying triggers— prompt treatment of infections, proper chronic disease management, and cautious use of drugs known to elevate white blood cell counts.
How long does a leukemoid reaction last?
The reaction is typically short-lived, resolving as soon as the underlying condition is successfully treated. Infections or inflammatory states that are rapidly managed often result in a quick normalization of white blood cell counts.
Should I be worried if my doctor suspects a leukemoid reaction?
While the reaction itself is not dangerous, it is a sign your body is actively fighting something that should be found and treated. Always follow up for further testing and management to ensure any serious underlying cause is identified and addressed.
Key Takeaways
- Leukemoid reaction is a marked, temporary rise in white blood cells, often resembling leukemia under a microscope.
- It is usually caused by infection, medication, stress, or other critical medical problems, and not by cancer itself.
- Distinguishing leukemoid reaction from leukemia requires specific laboratory and genetic testing.
- Treatment is targeted at the underlying cause; the reaction resolves when that cause is managed.
- The outlook depends wholly on how successfully the underlying issue is treated.
If you or someone you know is experiencing a dramatically elevated white blood cell count, consult your healthcare provider promptly. Early recognition and management of the underlying cause are key to a positive health outcome.
References
- https://en.wikipedia.org/wiki/Leukemoid_reaction
- https://www.healthline.com/health/leukemia/leukemoid-reaction
- https://www.medicalnewstoday.com/articles/leukemoid-reaction-vs-cml
- https://www.healthline.com/health/leukocyte-alkaline-phosphatase
- https://www.medicalnewstoday.com/articles/323090
- https://www.pennmedicine.org/conditions/leukemoid-reaction
- https://pubmed.ncbi.nlm.nih.gov/12739065/
- https://pubmed.ncbi.nlm.nih.gov/16962944/
- https://www.healthline.com/health/video/cll-community-stories-2
Read full bio of Sneha Tete